Beyond the Headlines, Columns-Drugs & Supplements, September 2005

September 22, 2005

FDA Approves Genetic Test for Drug Therapy Safety WASHINGTON, D.C. - A new blood test that will help doctors make personalized drug treatment decisions was approved by the Food and Drug Administration on Aug. 22. Third Wave Technologies' Invader UGT1A1 Molecular Assay detects variations in a gene that affects how certain drugs are broken down and cleared by the body, the FDA said, noting that doctors can use this information to help determine the right drug dosage for individual patients and minimize harmful drug reactions. Invader detects variations in the UGT1A1 gene that produces the … Subscribe Now Purchase Article for $40.00 Registered User Log In Email Address Password Login Forgot your username or password? UPCOMING CONFERENCES HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone June 27, 2024 - Buffalo, NY The Richardson Hotel Buffalo MORE DETAILS HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates May 29, 2024 - Salt Lake City, UT The Grand America Hotel MORE DETAILS Sign Up For Email Alerts × Email address Publications Asbestos Benzene & Emerging Toxic Torts Litigation Camp Lejeune & Water Contamination Drugs & Medical Devices MDL Mass Tort & Class Action Monitor Reinsurance & Arbitration Talcum Powder Litigation Report Close Submit